Your browser doesn't support javascript.
loading
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.
Gordon, Michael S; Robert, Francisco; Matei, Daniela; Mendelson, David S; Goldman, Jonathan W; Chiorean, E Gabriela; Strother, Robert M; Seon, Ben K; Figg, William D; Peer, Cody J; Alvarez, Delia; Adams, Bonne J; Theuer, Charles P; Rosen, Lee S.
Affiliation
  • Gordon MS; Pinnacle Oncology Hematology, Scottsdale, Arizona. mgordon@azpoh.com.
  • Robert F; University of Alabama, Birmingham, Alabama.
  • Matei D; Indiana University School of Medicine, Indianapolis, Indiana.
  • Mendelson DS; Pinnacle Oncology Hematology, Scottsdale, Arizona.
  • Goldman JW; UCLA Department of Medicine, Los Angeles, California.
  • Chiorean EG; Indiana University School of Medicine, Indianapolis, Indiana. University of Washington, Seattle, Washington.
  • Strother RM; Indiana University School of Medicine, Indianapolis, Indiana.
  • Seon BK; Roswell Park Cancer Institute, Buffalo, New York.
  • Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland.
  • Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland.
  • Alvarez D; TRACON Pharmaceuticals, San Diego, California.
  • Adams BJ; TRACON Pharmaceuticals, San Diego, California.
  • Theuer CP; TRACON Pharmaceuticals, San Diego, California.
  • Rosen LS; UCLA Department of Medicine, Los Angeles, California.
Clin Cancer Res ; 20(23): 5918-26, 2014 Dec 01.
Article in En | MEDLINE | ID: mdl-25261556

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United States